accelerating drug development for rare diseases through data sharing and analysis
Published 3 years ago • 285 plays • Length 29:30Download video MP4
Download video MP3
Similar videos
-
29:30
accelerating drug development for rare diseases through data sharing and analysis
-
2:27
jane larkindale - why are c-path drug development tools important in rare disease drug development?
-
1:24:07
regulatory pathway and applications in drug development for rare diseases
-
57:08
industry perspective on drug development in rare diseases
-
53:31
ai-powered real-world simulations for faster and value-based rare disease drug development
-
4:07
what is exciting to you about taking on this ambitious project?
-
3:27
what does the fda hope to achieve through developing the rare disease cures accelerator?
-
5:18
what is exciting to you about taking on this ambitious project?
-
4:12
why are high-quality standardized databases so critical for drug development?
-
4:17
rdca-dap: shortening the timeline for developing new treatments for rare diseases
-
48:02
rdca-dap - value of integrated data and analytics in rare disease drug development
-
45:31
derisking rare disease drug development and measuring impact and outcomes with andrew lo
-
8:03
rdca-dap: how the data and analytics platform accelerates rare disease drug development
-
2:33
rare disease patient voice: david fajgenbaum
-
3:39:01
data sharing to accelerate therapeutic development for rare diseases day 1
-
3:45:08
data sharing to accelerate therapeutic development for rare diseases day 2
-
22:01
optimization of clinical trial design for rare disease through modeling: example in duchenne’s
-
1:36:06
webinar: rdca-dap and eatris present rare disease drug development
-
46:37
clinical trial simulation tools advancing treatments in rare disease